BIRC5 and acute myeloid leukemia: Investigators have previously established survivin gene isoforms overexpression (survivin, -2B, -Ex3, and -3B, except survivin-2α) in the human AML-M3 cell line, NB4, as well as patient’s bone marrow samples, wherein their expression declined after arsenic trioxide treatment as a front-line therapy[12].